Literature DB >> 25550790

Isolation of myeloid-derived suppressor cells subsets from spleens of orthotopic liver cancer-bearing mice by fluorescent-activated and magnetic-activated cell sorting: similarities and differences.

Yaping Xu1, Wenxiu Zhao1, Duan Wu1, Jianfeng Xu1, Suqiong Lin1, Kai Tang1, Zhenyu Yin1, Xiaomin Wang1.   

Abstract

Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of immature myeloid cells that commonly expand during tumor development and that play a critical role in suppression of immune responses. MDSCs can be classified into two groups: Mo-MDSCs and G-MDSCs. These cells differ in their morphology, phenotype, differentiation ability, and immunosuppressive activity, and inhibit immune responses via different mechanisms. Therefore, identifying an effective method for isolating viable Mo-MDSCs and G-MDSCs is important. Here, we demonstrated the differences and similarities between fluorescence-activated cell sorting (FACS) and magnetic-activated cell sorting (MACS) in sorting G-MDSCs and Mo-MDSCs. Both MACS and FACS could obtain G-MDSCs and Mo-MDSCs with high viability and purity. A high yield and purity of G-MDSCs could be obtained both by using FACS and MACS, because G-MDSCs are highly expressed in the spleen of tumor-bearing mice. However, Mo-MDSCs, which comprise a small population among leukocytes, when sorted by MACS, could be obtained at much greater cell number, although with a slightly lower purity, than when sorted by FACS. In conclusion, we recommended using both FACS and MACS for isolating G-MDSCs, and using MACS for isolation of Mo-MDSCs.

Entities:  

Keywords:  Fluorescent-activated cell sorting (FACS); granulocytic; magnetic-activated cell sorting (MACS); monocytic; myeloid-derived suppressor cell; separation

Mesh:

Year:  2014        PMID: 25550790      PMCID: PMC4270530     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  32 in total

1.  The terminology issue for myeloid-derived suppressor cells.

Authors:  Dmitry I Gabrilovich; Vincenzo Bronte; Shu-Hsia Chen; Mario P Colombo; Augusto Ochoa; Suzanne Ostrand-Rosenberg; Hans Schreiber
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

2.  Neutrophil depletion protects against murine acetaminophen hepatotoxicity.

Authors:  Zhang-Xu Liu; Derick Han; Basuki Gunawan; Neil Kaplowitz
Journal:  Hepatology       Date:  2006-06       Impact factor: 17.425

3.  Cell separations by flow cytometry.

Authors:  D Davies
Journal:  Methods Mol Med       Date:  2001

4.  Vaccine-induced myeloid cell population dampens protective immunity to SIV.

Authors:  Yongjun Sui; Alison Hogg; Yichuan Wang; Blake Frey; Huifeng Yu; Zheng Xia; David Venzon; Katherine McKinnon; Jeremy Smedley; Mercy Gathuka; Dennis Klinman; Brandon F Keele; Sol Langermann; Linda Liu; Genoveffa Franchini; Jay A Berzofsky
Journal:  J Clin Invest       Date:  2014-05-16       Impact factor: 14.808

5.  Ly6C+ Ly6G- Myeloid-derived suppressor cells play a critical role in the resolution of acute inflammation and the subsequent tissue repair process after spinal cord injury.

Authors:  Hirokazu Saiwai; Hiromi Kumamaru; Yasuyuki Ohkawa; Kensuke Kubota; Kazu Kobayakawa; Hisakata Yamada; Takehiko Yokomizo; Yukihide Iwamoto; Seiji Okada
Journal:  J Neurochem       Date:  2013-01-15       Impact factor: 5.372

6.  Subset characterization of myeloid-derived suppressor cells arising during induction of BM chimerism in mice.

Authors:  A Luyckx; E Schouppe; O Rutgeerts; C Lenaerts; C Koks; S Fevery; T Devos; D Dierickx; M Waer; J A Van Ginderachter; A D Billiau
Journal:  Bone Marrow Transplant       Date:  2011-10-31       Impact factor: 5.483

7.  Subpopulations of myeloid-derived suppressor cells impair T cell responses through independent nitric oxide-related pathways.

Authors:  Patrick L Raber; Paul Thevenot; Rosa Sierra; Dorota Wyczechowska; Daniel Halle; Maria E Ramirez; Augusto C Ochoa; Matthew Fletcher; Cruz Velasco; Anna Wilk; Krzysztof Reiss; Paulo C Rodriguez
Journal:  Int J Cancer       Date:  2013-12-03       Impact factor: 7.396

8.  Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine.

Authors:  Paola Filipazzi; Roberta Valenti; Veronica Huber; Lorenzo Pilla; Paola Canese; Manuela Iero; Chiara Castelli; Luigi Mariani; Giorgio Parmiani; Licia Rivoltini
Journal:  J Clin Oncol       Date:  2007-06-20       Impact factor: 44.544

9.  Hepatic stellate cells promote tumor progression by enhancement of immunosuppressive cells in an orthotopic liver tumor mouse model.

Authors:  Wenxiu Zhao; Lei Zhang; Yaping Xu; Zhengqi Zhang; Guangli Ren; Kai Tang; Penghao Kuang; Bixing Zhao; Zhenyu Yin; Xiaomin Wang
Journal:  Lab Invest       Date:  2013-12-02       Impact factor: 5.662

10.  Anti-Gr-1 antibody depletion fails to eliminate hepatic myeloid-derived suppressor cells in tumor-bearing mice.

Authors:  Chi Ma; Tamar Kapanadze; Jaba Gamrekelashvili; Michael P Manns; Firouzeh Korangy; Tim F Greten
Journal:  J Leukoc Biol       Date:  2012-10-17       Impact factor: 4.962

View more
  2 in total

1.  In vitro exploration of a myeloid-derived suppressor cell line as vehicle for cancer gene therapy.

Authors:  S Denies; F Combes; C Ghekiere; S Mc Cafferty; L Cicchelero; N N Sanders
Journal:  Cancer Gene Ther       Date:  2016-11-18       Impact factor: 5.987

Review 2.  Utilization of lung cancer cell lines for the study of lung cancer stem cells.

Authors:  Yuyi Wang; Ming Jiang; Chi Du; Yang Yu; Yanyang Liu; Mei Li; Feng Luo
Journal:  Oncol Lett       Date:  2018-03-14       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.